191 related articles for article (PubMed ID: 15680459)
21. Treatment options for hepatic encephalopathy.
Schiano TD
Pharmacotherapy; 2010 May; 30(5 Pt 2):16S-21S. PubMed ID: 20412036
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of hepatic encephalopathy after portal shunt in the patient with cirrhosis].
Grange D; Bismuth H
Arch Fr Mal App Dig; 1975; 64(3):257-69. PubMed ID: 1108827
[No Abstract] [Full Text] [Related]
23. Portal-systemic encephalopathy and hepatic coma.
Jensen DM
Med Clin North Am; 1986 Sep; 70(5):1081-92. PubMed ID: 2874273
[TBL] [Abstract][Full Text] [Related]
24. [Emergency treatment of hepatic coma and porto-caval encephalopathy].
Imler M
Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):239-55. PubMed ID: 4589247
[No Abstract] [Full Text] [Related]
25. Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy.
Loguercio C; Abbiati R; Rinaldi M; Romano A; Del Vecchio Blanco C; Coltorti M
J Hepatol; 1995 Jul; 23(1):39-46. PubMed ID: 8530808
[TBL] [Abstract][Full Text] [Related]
26. Management of overt hepatic encephalopathy.
Khungar V; Poordad F
Clin Liver Dis; 2012 Feb; 16(1):73-89. PubMed ID: 22321466
[TBL] [Abstract][Full Text] [Related]
27. Effects of lactulose on nitrogen metabolism.
Weber FL
Scand J Gastroenterol Suppl; 1997; 222():83-7. PubMed ID: 9145455
[TBL] [Abstract][Full Text] [Related]
28. Hepatic encephalopathy: current status.
Schenker S; Breen KJ; Hoyumpa AM
Gastroenterology; 1974 Jan; 66(1):121-51. PubMed ID: 4588556
[No Abstract] [Full Text] [Related]
29. [Hepatic encephalopathy].
Bernardini AP; Silva Ade O
Arq Gastroenterol; 1984; 20(4):156-65. PubMed ID: 6146302
[TBL] [Abstract][Full Text] [Related]
30. Hepatic encephalopathy. Metabolic consequence of cirrhosis often is reversible.
Abou-Assi S; Vlahcevic ZR
Postgrad Med; 2001 Feb; 109(2):52-4, 57-60, 63-5 passim. PubMed ID: 11272694
[TBL] [Abstract][Full Text] [Related]
31. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
[TBL] [Abstract][Full Text] [Related]
32. Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.
Ndraha S; Simadibrata M
Acta Med Indones; 2010 Jul; 42(3):158-61. PubMed ID: 20724770
[TBL] [Abstract][Full Text] [Related]
33. Hepatic encephalopathy: pathophysiology and advances in therapy.
Av SP
Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
[TBL] [Abstract][Full Text] [Related]
34. [Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use].
Fehér J; Prónai L
Orv Hetil; 1993 Jun; 134(26):1417-9. PubMed ID: 8332363
[TBL] [Abstract][Full Text] [Related]
35. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
[No Abstract] [Full Text] [Related]
36. [Therapy of coma in liver cirrhosis].
Manenti F; Ferrari A
Clin Ter; 1975 Jul; 74(1):3-12. PubMed ID: 1222514
[No Abstract] [Full Text] [Related]
37. [Effect of differentiated diet therapy on the clinical results and biochemical indicators in chronic hepatic encephalopathy].
Szpakowicz T; Boroń P; Flisiak R; Bobrowska E; Kaczmarska A; Nowak HF; Zimnoch L
Przegl Lek; 1990; 47(7):527-31. PubMed ID: 2284419
[TBL] [Abstract][Full Text] [Related]
38. Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Wen J; Liu Q; Song J; Tong M; Peng L; Liang H
Digestion; 2013; 87(2):132-8. PubMed ID: 23485720
[TBL] [Abstract][Full Text] [Related]
39. Hepatic encephalopathy: current management strategies and treatment, including management and monitoring of cerebral edema and intracranial hypertension in fulminant hepatic failure.
Zafirova Z; O'connor M
Curr Opin Anaesthesiol; 2010 Apr; 23(2):121-7. PubMed ID: 20124996
[TBL] [Abstract][Full Text] [Related]
40. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
